Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy
Matthew Rees, Shaji Kumar
American Journal of Hematology (2024) Vol. 99, Iss. 8, pp. 1560-1575
Closed Access | Times Cited: 12

Showing 12 citing articles:

Novel Treatment Options for Multiple Myeloma
Andrew J. Portuguese, Rahul Banerjee, Gui Zhen Chen, et al.
JCO Oncology Practice (2025)
Closed Access
A Bayesian Joint Model of Multiple Nonlinear Longitudinal and Competing Risks Outcomes for Dynamic Prediction in Multiple Myeloma: Joint Estimation and Corrected Two‐Stage Approaches
Danilo Alvares, Jessica Barrett, François Mercier, et al.
Statistics in Medicine (2025) Vol. 44, Iss. 3-4
Open Access
Long-term trends in the burden of multiple myeloma in China: a Joinpoint regression and age-period-cohort analysis based on GBD 2021
Yanyu Zhang, Qing Su, Jiawen Yu, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
A novel mechanism in regulating drug sensitivity, growth, and apoptosis of bortezomib-resistant multiple myeloma cells: the USP4/KLF2/HMGA2 cascade
Ziyi Liu, Xiaoliang Li, Y. He, et al.
Journal of Orthopaedic Surgery and Research (2025) Vol. 20, Iss. 1
Open Access
Multiple myeloma as a challenging multidimensional random process: a data-driven web-based application for treatment selection
А. С. Лучинин, T. G. Gevorkyan, Anna Semenova
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access
Carfilzomib in multiple myeloma: unraveling cardiac toxicities - from mechanisms to diagnosis and management
Yi Gao, Di Zhou, Xue Bai, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Analysis of Ubiquitin-Conjugating Enzyme E2T (UBE2T) Protein Levels in the Bone Marrow Biopsy Specimens of Patients With Multiple Myeloma
Fei Wang, Na Yu, Rong Xia
Cureus (2025)
Open Access
Combining SKY92 gene expression profiling and FISH (according to R2‐ISS) defines ultra‐high‐risk Multiple Myeloma
Xiang Zhou, Annika Hofmann, Benedict Engel, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access
Systemic toxicity of CAR-T therapy and potential monitoring indicators for toxicity prevention
Jingxian Li, Huiguang Chen, Chaoping Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Real world outcome of high-risk multiple myeloma: an Indian tertiary care centre experience
Anveshika Soni, Sujay Rainchwar, Reema Singh, et al.
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access
Anticuerpos biespecíficos en el mieloma múltiple en recaída
Carlos Fernández-de Larrea, Luis Gerardo Rodríguez‐Lobato, Natalia Tovar, et al.
Revista Sangre (2024) Vol. 43, Iss. 92
Closed Access
Flower-Shaped Plasma Cells in Multiple Myeloma with Morphological Heterogeneity
Hiroki Hosoi, Misato Tane, Makiko Sogabe, et al.
Diagnostics (2024) Vol. 14, Iss. 20, pp. 2285-2285
Open Access
Page 1

Scroll to top